Clinical effectiveness of enzyme replacement therapy with galsulfase in mucopolysaccharidosis type VI treatment: systematic review
ConclusionThis review provided a broader panoramic view of the outcomes related to mucopolysaccharidosis type VI. Regardless of the inherent limitations of observational studies, the outcomes indicate that the enzyme replacement therapy has a positive effect on most of the outcomes associated to the disease.
Source: Journal of Inherited Metabolic Disease - Category: Internal Medicine Source Type: research
More News: Databases & Libraries | Internal Medicine | Liver | Orthopaedics | Rare Diseases | Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study | Urology & Nephrology